A Comparative Pharmaceutical-Clinical Study of Kandughna Mahakashaya In Two Different Dosage Form And Its Effect In Eczema

A Comparative Pharmaceutical And Clinical Study Of Kandughna Mahakashaya Vati And Taila And Their Effect On Vicharchika With Special Reference To Eczema - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076833

Enrollment

Registered

2024-11-14

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L239- Allergic contact dermatitis, unspecified cause

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with sign and symptoms of Vicharchika (Eczema) like Kandu (Itching), Pidika (Papules), Shyava (Blackish discolouration), Srava (Oozing), Rajyo (Disintegrity of skin), Ruja (Pain), Rukshta (Dryness) are selected for study. Patients having history with of one month or less than one months of origin of Vicharchika (Eczema).

Exclusion criteria

Exclusion criteria: Patients having age group of less than 16 years and above 60 years. Patients with any systemic disorders like uncontrolled hypertension, diabetes mellitus, hypothyroidism/hyperthyroidism and Pregnant & Lactating women. Patients who are using corticosteroid since long term. Patients of status Eczematous condition. Patients of Vicharchika (Eczema) having other skin disorder.

Design outcomes

Primary

Measure	Time frame
Improvement in Eczematous Lesions and ItchingTimepoint: 7 Days,14 Days,21 Days	—

Secondary

Measure	Time frame
Complete Relief In Eczematous Lesions And ItchingTimepoint: 28 Days	—

Countries

India

Contacts

Public ContactDr Vijay Kumar Rai

Government P.G Ayurvedic College And Hospital

drpaansari@gmail.com8081373553

Outcome results